Maylands_Healthcare_Limit - Accounts


Maylands Healthcare Limited
Unaudited Financial Statements
For Filing with Registrar
For the year ended 30 September 2020
Company Registration No. 07579931 (England and Wales)
Maylands Healthcare Limited
Company Information
Directors
Dr A. Aggarwal
Dr H. Jenkins
Dr N. Rao
Dr S. Shridhar
Dr S. Jothimurugan
Company number
07579931
Registered office
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Accountants
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Business address
300 Upper Rainham Road
Hornchurch
Essex
RM12 4EQ
Maylands Healthcare Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 4
Maylands Healthcare Limited
Balance Sheet
As at 30 September 2020
Page 1
2020
2019
Notes
£
£
£
£
Fixed assets
Investments
3
160,650
160,650
Current assets
Debtors
5
17,252
15,723
Cash at bank and in hand
663
663
17,915
16,386
Creditors: amounts falling due within one year
6
(54,655)
(52,063)
Net current liabilities
(36,740)
(35,677)
Total assets less current liabilities
123,910
124,973
Capital and reserves
Called up share capital
7
60
60
Profit and loss reserves
123,850
124,913
Total equity
123,910
124,973

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 30 June 2021 and are signed on its behalf by:
Dr N. Rao
Director
Company Registration No. 07579931
Maylands Healthcare Limited
Notes to the Financial Statements
For the year ended 30 September 2020
Page 2
1
Accounting policies
Company information

Maylands Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Orbital House, 20 Eastern Road, Romford, Essex, RM1 3PJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for thetrue foreseeable future and for a period of at least twelve months following the approval of these financial statements. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Investments

Fixed asset investments are stated at cost less provision for diminution in value.

1.4
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

All of the company's financial assets and liabilities are basic and measured at amortised cost.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 0 (2019: 0).

Maylands Healthcare Limited
Notes to the Financial Statements (Continued)
For the year ended 30 September 2020
Page 3
3
Fixed asset investments
2020
2019
£
£
Investments
160,650
160,650
Movements in fixed asset investments
Shares in group undertakings
£
Cost or valuation
At 1 October 2019 & 30 September 2020
160,650
Carrying amount
At 30 September 2020
160,650
At 30 September 2019
160,650
4
Subsidiaries

Holdings of more than 20%

The company holds more than 20% of the share capital of the following companies:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
Maylands Enterprises Limited
England & Wales
Provision of medical services
Ordinary
50.00
0
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Profit/(Loss)
Capital and Reserves
Maylands Enterprises Limited
8,739
(151,339)

The investment in Maylands Enterprises Limited includes £150 (2019: £150) ordinary shares and £160,500 (2019: £160,500) capital loan.

5
Debtors
2020
2019
Amounts falling due within one year:
£
£
Other debtors
17,252
15,723
Maylands Healthcare Limited
Notes to the Financial Statements (Continued)
For the year ended 30 September 2020
Page 4
6
Creditors: amounts falling due within one year
2020
2019
£
£
Other creditors
54,655
52,063
7
Called up share capital
2020
2019
£
£
Ordinary share capital
Issued and fully paid
10 Ordinary A shares of £1 each
10
10
10 Ordinary B shares of £1 each
10
10
10 Ordinary C shares of £1 each
10
10
10 Ordinary D shares of £1 each
10
10
10 Ordinary E shares of £1 each
10
10
10 Ordinary F shares of £1 each
10
10
60
60

All ordinary shares have attached to them full voting, dividend and capital distribution rights (including on winding up), and do not confer any rights of redemption. The shares rank pari passu in all respects save that dividends may be declared at different rates on the different share classes.

8
Directors' transactions

Included in other debtors at the year end is an amount of £17,252 (2019: £15,723) due from Maylands Healthcare Medical Practice of which some of the directors are partners.

 

Included in other creditors are amounts due to the directors as follows:

 

Dr H Jenkins £25,740 (2019: £25,223)

Dr S Jothimurugan £2,132 (2019: £1,613)

Dr S Shridhar £19,053 (2019: £18,535)

Dr N Rao £2,054 (2019: £1,535)

Dr A Aggarwal £2,054 (2019: £1,535)

 

 

2020-09-302019-10-01false30 June 2021CCH SoftwareCCH Accounts Production 2021.100No description of principal activityDr A. AggarwalDr H. JenkinsDr H. JenkinsDr N. RaoDr S. Shridhar075799312019-10-012020-09-3007579931bus:Director12019-10-012020-09-3007579931bus:Director32019-10-012020-09-3007579931bus:Director42019-10-012020-09-3007579931bus:Director52019-10-012020-09-3007579931bus:Director62019-10-012020-09-3007579931bus:Director22019-10-012020-09-3007579931bus:RegisteredOffice2019-10-012020-09-30075799312020-09-30075799312019-09-3007579931core:CurrentFinancialInstruments2020-09-3007579931core:CurrentFinancialInstruments2019-09-3007579931core:ShareCapital2020-09-3007579931core:ShareCapital2019-09-3007579931core:RetainedEarningsAccumulatedLosses2020-09-3007579931core:RetainedEarningsAccumulatedLosses2019-09-3007579931core:Subsidiary12019-10-012020-09-3007579931core:Subsidiary112019-10-012020-09-3007579931bus:PrivateLimitedCompanyLtd2019-10-012020-09-3007579931bus:SmallCompaniesRegimeForAccounts2019-10-012020-09-3007579931bus:FRS1022019-10-012020-09-3007579931bus:AuditExemptWithAccountantsReport2019-10-012020-09-3007579931bus:FullAccounts2019-10-012020-09-30xbrli:purexbrli:sharesiso4217:GBP